These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22924267)

  • 21. Pitfalls and caveats in BRCA sequencing.
    Bellosillo B; Tusquets I
    Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18. Genetics of breast cancer.
    Irving M; Elmslie F; Berg J
    Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
    Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
    Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
    Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
    Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Communicating BRCA1 and BRCA2 genetic test results.
    Gadzicki D; Wingen LU; Teige B; Horn D; Bosse K; Kreuz F; Goecke T; Schäfer D; Voigtländer T; Fischer B; Froster U; Welling B; Debatin I; Weber BH; Schönbuchner I; Nippert I; Schlegelberger B;
    J Clin Oncol; 2006 Jun; 24(18):2969-70; author reply 2970-1. PubMed ID: 16782939
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.
    Lessick M
    Nurs Womens Health; 2007 Aug; 11(4):390-9; quiz 400-1. PubMed ID: 17883756
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical management of BRCA1 and BRCA2 mutation carriers.
    Domchek SM; Armstrong K; Weber BL
    Nat Clin Pract Oncol; 2006 Jan; 3(1):2-3. PubMed ID: 16407858
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
    Bonadona V; Lasset C
    Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary breast cancer.
    Hill AD; Doyle JM; McDermott EW; O'Higgins NJ
    Br J Surg; 1997 Oct; 84(10):1334-9. PubMed ID: 9361585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].
    Pujol P; This P; Noruzinia M; Stoppa-Lyonnet D; Maudelonde T
    Bull Cancer; 2004; 91(7-8):583-91. PubMed ID: 15381448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
    Janatova M; Kleibl Z; Stribrna J; Panczak A; Vesela K; Zimovjanova M; Kleiblova P; Dundr P; Soukupova J; Pohlreich P
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2323-32. PubMed ID: 24136930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy].
    Levanat S; Cvok ML
    Lijec Vjesn; 2010; 132(1-2):34-7. PubMed ID: 20359158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic testing and familial implications in breast-ovarian cancer families.
    Oosterwijk JC; de Vries J; Mourits MJ; de Bock GH
    Maturitas; 2014 Aug; 78(4):252-7. PubMed ID: 24894332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.
    Domchek SM; Rebbeck TR
    LDI Issue Brief; 2010; 16(2):1-4. PubMed ID: 21545057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary breast cancer and genetic counseling in young women.
    Brunet J
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inherited breast and ovarian cancers].
    Gerdes AM; Ejlertsen B
    Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical practice. Management of an inherited predisposition to breast cancer.
    Robson M; Offit K
    N Engl J Med; 2007 Jul; 357(2):154-62. PubMed ID: 17625127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.